Related Links
- NT-proBNP for Rapid Optimisation of GDMT in AHF Patients in Japan
- Communicating the value of CVD screening in T2DM to patients
- STRONG-HF: Enhancing GDMT regimen in Asia
- Heart Failure Care Beyond City Limits: Insights from a Cardiologist
- Implementation of STRONG-HF protocol in heart failure management: an Australian perspective
- Unleashing the Power of STRONG-HF: Enabling Transformation in Heart Failure Management Across China
- Elevating CVD management in APAC to its Zenith- with Cardiac biomarkers
- Heart failure management in Australia and the role of NT-proBNP in monitoring and treatment
- Download APAC STRONG-HF Master Pack: First-hand Insights from Prof Mebazaa on Heart Failure Treatment Monitoring
- Heart Failure Management in India – Overcoming Present Challenges
- NT-proBNP and ECHO in heart failure – do they always go hand in hand?
- Value of NT-ProBNP for Treatment Monitoring in CHF
- Clinical Cases from Korea: Value of NT-proBNP in Cardiomyopathy
- Clinical Cases from Korea: High NT-proBNP levels useful in differential diagnosis of HF
- How to Use NT-proBNP for Prognosis and Monitoring?